The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Thanks Blue, should be a good 'un. Just need the AGM vote to get passed and it should be a green light. Could sensibly target new highs. Yes, I saw that this morning - had the pleasure of reading in the 'intimate' surroundings of the tube at rush hour...thought it was really good. If that's how your rivals describe you than that's fantastic - 'pushy' is the mantra of sales! I have a similarly vast holding. Price for diversification! I'd recommend iweb (if you're not with 'em already) - £5 dealing costs. Saved me over £500 per year vs HL
Is there a price at which you become interested? I was going to buy at 15p, but invested funds elsewhere. Results have been uninspiring, but m/c is low for such a big name player with decent revenues and an international footprint. SFO may cause further reputational damage, but I don't see them doing much else - they seem to bungle most high profile investigations (Tchenguiz being the worst)
Joined you here...good coverage in the papers this morning, hopefully that continues over the weekend and we see more buying next week. Missed the first 10% of the rise, but should be plenty more, results next week too
Libero, thanks for posting the stuff from Paul and Jimbo, it's interesting getting other perspectives. I think that some of the fall was down the comparison between the headline figures of H1 and FY, as discussed below. PMR good positive coverage in last night's Evening Standard and this morning's City AM, so hopefully that'll increase the profile. They have considered several acquisitions already this year, so may be lining up using some of the cash for that.
Now closer to 4 lol. Didn't expect the fall...but bought more at 125p, taking my average to about 130p. H2 inferred was weaker than H1, but not dramatically so... FY EPS was lower than H1 alone, but as noted earlier this is primarily a result of the redundancy/restructuring costs that fell into H2. H1 2015 has started well - so at this price seems good value all things considered. I think a target of 170-200p would be reasonable, but may happy to be flexible
£6m increase in cash to £12m - still a £21m m/c. Gives an EV/EBIT of 4-5. Net assets exceed m/c. Dividend restated, positive outlook. Only slight blemish is the £1m of redundancy and restructuring in H2 (which makes H2 look weaker than it was) - but this is only in line with the 2013 figure. I'll email them a question about this when I get chance and post any answer.
Well done on the flip though lol...envious of your knack!
Haven't seen broker report, is there a link or were you sent it by your own? I know that PMR have it as a buy with a 33p target. Yes, although the banks have demonstrated considerable support to date. I think Henderson could go a bit further than their rather paltry assistance to date, given they are such a large ii. There's also a possibility that one of Matt Cooper's other interests could offer support in a similar fashion to Henderson? As long as it's not convertible loan notes! More broadly, there's obviously significant execution risk. I think therefore that it should probably trade at a slight discount to OPM (who have demonstrated relatively successful partial execution), but not to this extent. As we've said before, management are well aligned have have good relevant experience...so optimistic generally. In a worst case scenario, if they prove the growth prospects with their revenue and operating profit any placing should be well supported. Relaxed about ebb and flow of these smaller movements, looking at the chart there's precedent for meaningless rises and falls
...there's a large volume of small sells. I think that has been mirrored at times in the past, back in the Renovo days! Perhaps the legacy seller lives on
Bought back today for tomorrow's results. From the recent transactions section of their website the brokerage side looked busier H2 14 than H2 14, but little indication of how the other departments have performed. Hopefully given the strong H1 the full year will be show yoy improvement. I don't think the dividend will be back just yet though.
Under-ramped, but the 36k buyer sees it
Just passing through here, but read your posts and think your opinion would be welcomed over on GBO. Very little comment on the technical aspects over there, and your insight would be appreciated
But precarious rating?
The average trade size here is much bigger than most small caps...despite illiquidity. An ii perhaps? Or just wealthier PIs than normal? Either way, plenty agree with your analyis of c.£4 being cheap
Thanks. Seems excessive for relatively low skilled / everyday employees (going off linkedin only) but this is the City so perhaps I shouldn't be surpised!
What price for bottom Blue? 20p psychological support with an intraday dip below on any placing? Finger in the wind time!
I had to google that Jolly, very obscure choice! Apparently popular in the 1860s... Shan his Share Sleuth is really good, with only a few odd calls here and there (i.e. Games Workshop - from your home town lol). The Thrifty Fifty seems pretty dire - not keen on PI designed stat trading models.
of decent sized buys over £4 now...next stop 4.50
I accept your point about the typhoon, but am more concerned about the trend in the business (disregarding the share price trend for the moment, though the two are obviously partially interlinked). The canker is obviously relatively exceptional too, but I gather quite common in Asia. They also said initially that it wasn't a big deal. Then suddenly it was.There are other excuses too, such as the dying of oranges by regional competitors, and the supposed misreports from regional rivals. Also, if you read back through older statements, you can see a gradual decline. Every trading/results statement I read seemed to show a decline. When was the last increase in revenue/profit? This isn't a new business, so can't be judged solely on recent misfortunes. I don't think it's necessarily a sell at these levels, but don't it as a compelling investment. That may change if the management can demonstrate a year on year increase in profit/cash flow - given the extenuating circumstances affecting past profits, that should be achievable.
just quiet... JV sounds interesting Current fair value somewhere low-mid 20s imv (with room for growth if management continue to deliver)